PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

NCT05071872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2023-02-09

No results posted yet for this study

Summary

Retrospective Post-Market Clinical Follow Up of Rotarex®S \& Aspirex®S Catheters in treating thrombotic occlusion of Arteriovenous Graft for dialysis access (Artificial Bypass)

Conditions

  • Arteriovenous Graft Thrombosis

Interventions

DEVICE

Atherectomy/Thrombectomy

Percutaneous transluminal removal of thrombotic occlusion in arteriovenous graft

Sponsors & Collaborators

  • Straub Medical AG

    lead INDUSTRY

Principal Investigators

  • Samuel Heller, M.D. · Angiocentrum Příbram

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-06
Primary Completion
2022-06-08
Completion
2022-06-08

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071872 on ClinicalTrials.gov